Kaufman KD, Olsen EA, Whiting D, Savin R, DeVillez R, Bergfeld W, Price VH, Van Neste D, Roberts JL, Hordinsky M, Shapiro J, Binkowitz B, Gormley GJ (1998) Finasteride in the treatment of men with androgenetic alopecia finasteride male pattern hair loss study group. J Am Acad Dermatol. https://doi.org/10.1016/S0190-9622(98)70007-6

Article  PubMed  Google Scholar 

Edwards JE, Moore RA (2002) Finasteride in the treatment of clinical benign prostatic hyperplasia: a systematic review of randomised trials. BMC Urol 2:14

Article  PubMed  PubMed Central  Google Scholar 

Fwu CW, Eggers PW, Kirkali Z, McVary KT, Burrows PK, Kusek JW (2014) Change in sexual function in men with lower urinary tract symptoms/benign prostatic hyperplasia associated with long-term treatment with doxazosin, finasteride and combined therapy. J Urol 191(6):1828–1834. https://doi.org/10.1016/j.juro.2013.12.014

Article  CAS  PubMed  Google Scholar 

Traish AM, Melcangi RC, Bortolato M, Garcia-Segura LM, Zitzmann M (2015) Adverse effects of 5alpha-reductase inhibitors: What do we know, don’t know, and need to know? Rev Endocr Metab Disord 16:177–198. https://doi.org/10.1007/s11154-015-9319-y

Article  CAS  PubMed  Google Scholar 

Belknap SM, Aslam I, Kiguradze T, Temps WH, Yarnold PR, Cashy J, Brannigan RE, Micali G, Nardone B, West DP (2015) Adverse event reporting in clinical trials of finasteride for androgenic alopecia: a meta-analysis. JAMA Dermatol 151(6):600–606. https://doi.org/10.1001/jamadermatol.2015.36

Article  PubMed  Google Scholar 

Diviccaro S, Melcangi RC, Giatti S (2020) Post-finasteride syndrome: an emerging clinical problem. Neurobiol Stress 12:100209. https://doi.org/10.1016/j.ynstr.2019.100209

Article  PubMed  Google Scholar 

Motofei IG, Rowland DL, Georgescu SR, Baconi DL, Dimcevici NP, Paunica S, Constantin VD, Balalau C (2013) A pilot study on the sexual side effects of finasteride as related to hand preference for men undergoing treatment of male pattern baldness. BJU Int. https://doi.org/10.1111/j.1464-410X.2012.11580.x

Article  PubMed  Google Scholar 

Motofei IG, Rowland DL, Georgescu SR, Tampa M, Baconi D, Stefanescu E, Baleanu BC, Balalau C, Constantin V, Paunica S (2016) Finasteride adverse effects in subjects with androgenic alopecia: a possible therapeutic approach according to the lateralization process of the brain. J Dermatol Treat. https://doi.org/10.3109/09546634.2016.1161155

Article  Google Scholar 

Irwig MS, Kolukula S (2011) Persistent sexual side effects of finasteride for male pattern hair loss. J Sex Med 8(6):1747–1753. https://doi.org/10.1111/j.1743-6109.2011.02255.x

Article  PubMed  Google Scholar 

Irwig MS (2012) Persistent sexual side effects of finasteride: could they be permanent? J Sex Med 9(11):2927–2932. https://doi.org/10.1111/j.1743-6109.2012.02846.x

Article  PubMed  Google Scholar 

Ganzer CA, Jacobs AR, Iqbal F (2015) Persistent sexual, emotional, and cognitive impairment post-finasteride: a survey of men reporting symptoms. Am J Mens Health 9(3):222–228. https://doi.org/10.1177/1557988314538445

Article  PubMed  Google Scholar 

Basaria S, Jasuja R, Huang G, Wharton W, Pan H, Pencina K, Li Z, Travison TG, Bhawan J, Gonthier R, Labrie F, Dury AY, Serra C, Papazian A, O’Leary M, Amr S, Storer TW, Stern E, Bhasin S (2016) Characteristics of men who report persistent sexual symptoms after finasteride use for hair loss. J Clin Endocrinol Metab 101(12):4669–4680. https://doi.org/10.1210/jc.2016-2726

Article  CAS  PubMed  PubMed Central  Google Scholar 

Melcangi RC, Santi D, Spezzano R, Grimoldi M, Tabacchi T, Fusco ML, Diviccaro S, Giatti S, Carra G, Caruso D, Simoni M, Cavaletti G (2017) Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients. J Steroid Biochem Mol Biol 171:229–235. https://doi.org/10.1016/j.jsbmb.2017.04.003

Article  CAS  PubMed  Google Scholar 

Khera M, Than JK, Anaissie J, Antar A, Song W, Losso B, Pastuszak A, Kohn T, Mirabal JR (2020) Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia. Transl Androl Urol 9(3):1201–1209. https://doi.org/10.21037/tau.2020.03.21

Article  PubMed  PubMed Central  Google Scholar 

Melcangi RC, Caruso D, Abbiati F, Giatti S, Calabrese D, Piazza F, Cavaletti G (2013) Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology. J Sex Med 10(10):2598–2603. https://doi.org/10.1111/jsm.12269

Article  CAS  PubMed  Google Scholar 

Caruso D, Abbiati F, Giatti S, Romano S, Fusco L, Cavaletti G, Melcangi RC (2015) Patients treated for male pattern hair with finasteride show, after discontinuation of the drug, altered levels of neuroactive steroids in cerebrospinal fluid and plasma. J Steroid Biochem Mol Biol 146:74–79. https://doi.org/10.1016/j.jsbmb.2014.03.012

Article  CAS  PubMed  Google Scholar 

Giatti S, Foglio B, Romano S, Pesaresi M, Panzica G, Garcia-Segura LM, Caruso D, Melcangi RC (2016) Effects of subchronic finasteride treatment and withdrawal on neuroactive steroid levels and their receptors in the male rat brain. Neuroendocrinology 103(6):746–757. https://doi.org/10.1159/000442982

Article  CAS  PubMed  Google Scholar 

Di Loreto C, La Marra F, Mazzon G, Belgrano E, Trombetta C, Cauci S (2014) Immunohistochemical evaluation of androgen receptor and nerve structure density in human prepuce from patients with persistent sexual side effects after finasteride use for androgenetic alopecia. PLoS ONE 9(6):e100237. https://doi.org/10.1371/journal.pone.0100237

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cecchin E, De Mattia E, Mazzon G, Cauci S, Trombetta C, Toffoli G (2014) A pharmacogenetic survey of androgen receptor (CAG)n and (GGN)n polymorphisms in patients experiencing long term side effects after finasteride discontinuation. Int J Biol Markers 29(4):e310-316. https://doi.org/10.5301/jbm.5000095

Article  CAS  PubMed  Google Scholar 

Cauci S, Chiriaco G, Cecchin E, Toffoli G, Xodo S, Stinco G, Trombetta C (2017) Androgen receptor (AR) gene (CAG)n and (GGN)n length polymorphisms and symptoms in young males with long-lasting adverse effects after finasteride use against androgenic alopecia. Sex Med 5(1):e61–e71. https://doi.org/10.1016/j.esxm.2016.11.001

Article  PubMed  Google Scholar 

Melcangi RC, Giatti S, Garcia-Segura LM (2016) Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: sex-specific features. Neurosci Biobehav Rev 67:25–40. https://doi.org/10.1016/j.neubiorev.2015.09.023

Article  CAS  PubMed  Google Scholar 

Borgo F, Macandog AD, Diviccaro S, Falvo E, Giatti S, Cavaletti G, Melcangi RC (2020) Alterations of gut microbiota composition in post-finasteride patients: a pilot study. J Endocrinol Invest 44:1263–1273. https://doi.org/10.1007/s40618-020-01424-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diviccaro S, Giatti S, Cioffi L, Falvo E, Herian M, Caruso D, Melcangi RC (2022) Gut Inflammation induced by finasteride withdrawal: therapeutic effect of allopregnanolone in adult male rats. Biomolecules 12(11):1567. https://doi.org/10.3390/biom12111567

Article  CAS  PubMed  PubMed Central  Google Scholar 

Diviccaro S, Giatti S, Borgo F, Barcella M, Borghi E, Trejo JL, Garcia-Segura LM, Melcangi RC (2019) Treatment of male rats with finasteride, an inhibitor of 5alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition. Psychoneuroendocrinology 99:206–215. https://doi.org/10.1016/j.psyneuen.2018.09.021

Article  CAS  PubMed  Google Scholar 

Diviccaro S, Herian M, Cioffi L, Audano M, Mitro N, Caruso D, Giatti S, Melcangi RC (2023) Exploring rat corpus cavernosum alterations induced by finasteride treatment and withdrawal. Andrology. https://doi.org/10.1111/andr.13515

Article  PubMed  Google Scholar 

Giatti S, Di Domizio A, Diviccaro S, Falvo E, Caruso D, Contini A, Melcangi RC (2021) Three-dimensional proteome-wide scale screening for the 5-alpha reductase inhibitor finasteride: identification of a novel off-target. J Med Chem 64(8):4553–4566. https://doi.org/10.1021/acs.jmedchem.0c02039

Article  CAS  PubMed  PubMed Central  Google Scholar